Estadísticas de Efficacy and safety of pembrolizumab plus docetaxel vs docetaxel alone in patients with previously treated advanced non-small cell lung cancer: the PROLUNG Phase 2 randomized clinical trial
Visitas totales
views | |
---|---|
Efficacy and safety of pembrolizumab plus docetaxel vs docetaxel alone in patients with previously treated advanced non-small cell lung cancer: the PROLUNG Phase 2 randomized clinical trial | 0 |
Visitas totales por mes
views | |
---|---|
mayo 2024 | 0 |
junio 2024 | 0 |
julio 2024 | 0 |
agosto 2024 | 0 |
septiembre 2024 | 0 |
octubre 2024 | 0 |
noviembre 2024 | 0 |